Compliance of Radiotherapy Treatment at a Tertiary Cancer Center in India—A Clinical Audit

Abstract

Introduction Noncompliance to planned radiotherapy (RT) treatment is associated with inferior outcomes and also serves as an indicator of quality of care offered to the patients. Identification of the rate of noncompliance and its causative factors can help us develop an insight toward implementing mitigation measures thereby improving the quality of treatment.

Objective To ascertain the incidence of noncompliance and the factors affecting the same in patients offered RT appointments.

Materials and Methods We retrospectively reviewed the records of patients from January 1, 2019, to December 31, 2019, who were noncompliant (defaulted RT simulation or defaulted initiation of RT or defaulted planned RT during the course of RT but excluding planned/unplanned treatment breaks or early conclusions prescribed by the treating radiation oncologist) for the planned RT treatment.

Results Of the 8,607 appointments (7,699 external beam RT and 908 brachytherapy) given to the patients attending the radiation oncology outpatient department in the year 2019, a total of 197 (2.28%) patients were found to be noncomplaint. Ninety-seven patients defaulted RT simulation (49.2%), 53 defaulted RT starting (26.9%), and 47 defaulted while on RT (23.9%). Half of these had either head–neck (29.9%) or gynecological (20.8%) malignancies. Patients with breast cancers had the least noncompliance rates (0.02%). The cause for noncompliance was ascertained in 135 patients (68.5%). The common causes of noncompliance were the desire to continue treatment closer to home (21.5%) followed by logistic (17%), lack of confidence in the curative potential of the planned therapy (17%), and financial reasons (11.8%). Patients with head–neck and gynecological malignancies were more often with advanced staged disease and were planned multimodal treatment protocols. The majority of the 23 patients who defaulted palliative RT were planned for fractionated treatments (73.9%).

Conclusion The incidence of noncompliance in patients planned for RT in our institute can be considered optimum. Appropriate counseling of patients at the time of scheduling appointment, upfront identification of patients at high risk of noncompliance, and assisting patients with financial and logistic challenges are imperative to ensure adherence to planned treatment schedule.

Keywords

compliance - external beam - radiotherapy

Note

The manuscript has been read and approved by all the authors, the requirements for authorship have been met, and that each author believes that the manuscript represents honest work.

Publication History

Article published online:
27 February 2022

• References

• 1 Badakhshi H, Gruen A, Sehouli J, Budach V, Boehmer D. The impact of patient compliance with adjuvant radiotherapy: a comprehensive cohort study. Cancer Med 2013; 2 (05) 712-717
• 2 Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 2007; 68 (03) 654-661
• 3 Khalil AA, Bentzen SM, Bernier J. et al. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Int J Radiat Oncol Biol Phys 2003; 55 (03) 568-575
• 4 Ohri N, Rapkin BD, Guha C, Kalnicki S, Garg M. Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center. Int J Radiat Oncol Biol Phys 2016; 95 (02) 563-570
• 5 Fairchild A, Straube W, Laurie F, Followill D. Does quality of radiation therapy predict outcomes of multicenter cooperative group trials? A literature review. Int J Radiat Oncol Biol Phys 2013; 87 (02) 246-260
• 6 Mohanti BK, Nachiappan P, Pandey RM, Sharma A, Bahadur S, Thakar A. Analysis of 2167 head and neck cancer patients' management, treatment compliance and outcomes from a regional cancer centre, Delhi, India. J Laryngol Otol 2007; 121 (01) 49-56
• 7 Sharma A, Madan R, Kumar R. et al. Compliance to therapy-elderly head and neck carcinoma patients. Can Geriatr J 2014; 17 (03) 83-87
• 8 Pandey KC, Revannasiddaiah S, Pant NK. Evaluation of factors in relation with the non- compliance to curative intent radiotherapy among patients of head and neck carcinoma: a study from the Kumaon region of India. Indian J Palliat Care 2015; 21 (01) 21-26
• 9 Gupta S, Rastogi K, Bhatnagar AR, Singh D, Gupta K, Choudhary AS. Compliance to radiotherapy: a tertiary care center experience. Indian J Cancer 2018; 55 (02) 166-169
• 10 Palwe V, Patil R, Pandit P. et al. Factors influencing non-adherence to radiotherapy: a retrospective audit of 1,548 patients from a tertiary cancer centre. J Radiother Pract 2019; 19 (04) 1-6
• 11 Dutta S, Biswas N, Muhkherjee G. Evaluation of socio-demographic factors for non-compliance to treatment in locally advanced cases of cancer cervix in a rural medical college hospital in India. Indian J Palliat Care 2013; 19 (03) 158-165
• 12 Ohri N, Rapkin BD, Guha D. et al. Predictors of radiation therapy noncompliance in an urban academic cancer center. Int J Radiat Oncol Biol Phys 2015; 91 (01) 232-238
• 13 Borras JM, Font R, Solà J. et al. Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain. Radiother Oncol 2020; 151: 200-205
• 14 Bhatt CR, Sharan K, Ninan J, Sathian B, Ween B, Olsen DR. Cancer treatment by radiotherapy in Western Nepal: a hospital-based study. Asian Pac J Cancer Prev 2009; 10 (02) 205-208
• 15 Arrossi S, Matos E, Zengarini N, Roth B, Sankaranayananan R, Parkin M. The socio-economic impact of cervical cancer on patients and their families in Argentina, and its influence on radiotherapy compliance. Results from a cross-sectional study. Gynecol Oncol 2007; 105 (02) 335-340
• 16 Ferreira BC, Sá-Couto P, Lopes MC, Khouri L. Compliance to radiation therapy of head and neck cancer patients and impact on treatment outcome. Clin Transl Oncol 2016; 18 (07) 677-684
• 17 Ma AMT, Barone J, Wallis AE. et al. Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. Am J Surg 2008; 196 (04) 500-504
• 18 Patel UA, Thakkar KH, Holloway N. Patient compliance to radiation for advanced head and neck cancer at a tertiary care county hospital. Laryngoscope 2008; 118 (03) 428-432
• 19 Sayan M, Eren MF, Kotek A. et al. Utilization of radiation therapy and predictors of noncompliance among Syrian refugees with cancer living in Turkey. Int J Radiat Oncol Biol Phys 2020; 108 (03) S135
• 20 Potters L, Raince J, Chou H. et al. Development, implementation, and compliance of treatment pathways in radiation medicine. Front Oncol 2013; 3: 105
• 21 Jihan A, Asma A, Fatima ZL. et al. Treatment Compliance and Radiation Associated Toxicities in Old Versus Young Patients: Prospective Comparative Case-Control Study. J Nucl Med Radiat Ther 2018; 9 (04) 373
• 22 Number of people with health insurance across India from financial year 2016 to 2020, by business type. Accessed 27 January 2022 at: https://www.statista.com/statistics/657244/number-of-people-with-health-insuranceindia/#:∼:text=In%20the%20fiscal%20year%20of,the%20lowest%20number%20of%20people
• 23 Thomas K, Martin T, Gao A, Ahn C, Wilhelm H, Schwartz DL. Interruptions of head and neck radiotherapy across insured and indigent patient populations. J Oncol Pract 2017; 13 (04) e319-e328
• 24 Wollschläger D, Meng X, Wöckel A. et al. Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients. Breast J 2018; 24 (02) 120-127
• 25 Jatia S, Prasad M, Paradkar A. et al. Holistic support coupled with prospective tracking reduces abandonment in childhood cancers: a report from India. Pediatr Blood Cancer 2019; 66 (06) e27716
• 26 Rudat V, Nour A, Hammoud M. et al. Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy: Results of a single, institutional, retrospective study. Strahlenther Onkol 2017; 193 (05) 375-384